Investigational Site Number 8403005 — Burke, Virginia

Investigational Site Number 8403005 is a clinical research site located in Burke, Virginia, United States 22015.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 8403005 has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Lexicon Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Burke

Browse all research sites in Virginia · View every site in Burke

• Kaiser Permanente-Burke Medical Center
• PI-Coor Clinical Research
• Research Site
• GSK Investigational Site
• Burke Internal Medicine and Research
• Burke Internal Medicine & Research
• Burke Internal Medicine
• Local Institution
• Clinical Trial Site
• Novartis Investigative Site
• Altana Pharma/Nycomed
• 89Bio Clinical Study Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 8403005?

Investigational Site Number 8403005 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 8403005 conducted?

Investigational Site Number 8403005 has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Investigational Site Number 8403005 accredited by Crixeo Clinical Trials?

Investigational Site Number 8403005 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 8403005?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.